Categories AlphaGraphs, Earnings, Health Care

A visual representation of Trxade Group (MEDS) Q1 2020 earnings

Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the market opens. The bottom-line soared by 44% as platform sales drove the top-line higher by 46%.

Trxade Group Inc. (NASDAQ: MEDS) reported Q1 2020 earnings results

The company continued to expand its trading platform organically, with 305 new independent pharmacies registered in Q1 2020. The average purchases per pharmacy increased on the Trxade platform by 13.7% in the first quarter of 2020, when compared to the same year-ago quarter.

During Q1, the company took strategic measures to enhance its corporate position, uplisting its common stock to the Nasdaq Capital Market and engaging an investor relations firm to implement a comprehensive capital markets strategy.

Take a look at our Health Care articles here
Also Read:  Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript

Most Popular

Major earnings conferences to watch this week

After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the

Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why

Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through strategic partnerships and technological innovation. Its performance so

The COVID-19 pandemic gave these companies an unexpected opportunity

The COVID-19 pandemic raged through the first half of this year and continues to impact the world without signs of abating. Amid this health crisis, several companies reported strong results